Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2022-11-09 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares'. It details the purchase of ordinary shares as part of a 'Share Buyback Programme' on a specific date (8 November 2022), including volume, highest, lowest, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (POS - Share Repurchase/Issuance). The RNS Number (7445F) and the date (09 November 2022) confirm it is a regulatory announcement regarding this specific corporate action.
2022-11-09 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled 'Transaction in Own Shares' and details the purchase of ordinary shares by PureTech Health PLC as part of its Share Buyback Programme. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares', which maps to the filing type code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The RNS Number suggests it is a regulatory announcement, but the content is specific enough to use the dedicated code POS.
2022-11-08 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and details the purchase of ordinary shares by PureTech Health PLC as part of its Share Buyback Programme. It provides specific transaction dates, volumes, and prices. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The appropriate filing code is POS.
2022-11-07 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares' and references a 'Share Buyback Programme'. It details the number of ordinary shares purchased, the prices paid, and the resulting treasury share balance. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company buying back or selling its own shares.
2022-11-04 English
6-K
Transaction in Own Shares Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, PureTech Health plc, reporting on a $50 million share repurchase program and detailing daily purchases of its own shares during October 2022. The content focuses on the company's transactions in its own shares, including quantities, prices, and dates, and references regulatory compliance with UK and EU rules. There is no financial statement or earnings data, no management discussion of results, no audit information, or other report types. The document is a regulatory filing reporting transactions in the company's own shares, which fits the category of Transaction in Own Shares (POS). The document length is 6470 characters, which is sufficient to contain detailed transaction data rather than a brief announcement. Therefore, the appropriate classification is POS with high confidence.
2022-11-03 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled 'Transaction in Own Shares' and details the purchase of ordinary shares by PureTech Health PLC as part of its Share Buyback Programme. It provides specific transaction dates, volumes, and prices. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing is also identified as an RNS release, which is a general regulatory announcement, but the specific content points overwhelmingly to the 'Transaction in Own Shares' category (POS).
2022-11-03 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.